Savara (SVRA) to Post Earnings on Wednesday

Savara (NASDAQ:SVRA – Get Free Report) is expected to be announcing its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $2.00 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 4:00 PM ET.

Savara (NASDAQ:SVRA – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.01). On average, analysts expect Savara to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Get Savara alerts:

Savara Stock Performance

NASDAQ SVRA opened at $5.41 on Wednesday. The company has a current ratio of 13.47, a quick ratio of 13.47 and a debt-to-equity ratio of 0.17. The stock has a market cap of $1.11 billion, a PE ratio of -9.66 and a beta of 0.29. The stock has a fifty day simple moving average of $5.59 and a 200-day simple moving average of $5.50. Savara has a twelve month low of $2.43 and a twelve month high of $7.01.

Institutional Investors Weigh In On Savara

Several institutional investors and hedge funds have recently made changes to their positions in the business. Prudential Financial Inc. acquired a new position in shares of Savara in the second quarter worth $30,000. BNP Paribas Financial Markets increased its position in shares of Savara by 52.3% during the second quarter. BNP Paribas Financial Markets now owns 13,473 shares of the company’s stock worth $31,000 after acquiring an additional 4,626 shares during the last quarter. Brevan Howard Capital Management LP acquired a new stake in shares of Savara in the 2nd quarter valued at about $33,000. Russell Investments Group Ltd. boosted its holdings in shares of Savara by 930.5% in the 3rd quarter. Russell Investments Group Ltd. now owns 10,480 shares of the company’s stock valued at $37,000 after buying an additional 9,463 shares during the period. Finally, CIBC Bancorp USA Inc. bought a new stake in shares of Savara during the third quarter valued at approximately $44,000. 87.93% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on SVRA shares. Oppenheimer assumed coverage on Savara in a research report on Friday, April 24th. They set an “outperform” rating and a $11.00 price objective on the stock. Wall Street Zen raised shares of Savara from a “sell” rating to a “hold” rating in a report on Saturday, June 13th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Savara in a research report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $10.14.

Check Out Our Latest Report on SVRA

Savara Company Profile

(Get Free Report)

Savara Inc (NASDAQ:SVRA) is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare respiratory diseases. The company specializes in in-licensing, advancing and potentially bringing to market novel treatments that address severe pulmonary conditions with high unmet medical need.

The company’s lead candidate, Molgradex (recombinant human granulocyte-macrophage colony-stimulating factor, or GM-CSF), is under regulatory review for the treatment of autoimmune pulmonary alveolar proteinosis (PAP), a rare lung disease characterized by the accumulation of surfactant.

Featured Stories

• Five stocks we like better than Savara
• Caterpillar’s Record Quarter May Have Reset the Stock’s Ceiling
• The Real Reason Amazon Hit a $3 Trillion Valuation
• System Upgrade: First Internet Bancorp Options Surge
• AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push

Receive News & Ratings for Savara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savara and related companies with MarketBeat.com's FREE daily email newsletter.